Fifth Third Bancorp
ECYT

Fifth Third Bancorp’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Fifth Third Bancorp’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,500
Closed -$8K – 3077
2015
Q2 		$8K Hold
1,500
– – ﹤0.01% 2184
2015
Q1 		$9K Hold
1,500
– – ﹤0.01% 2064
2014
Q4 		$9K Hold
1,500
– – ﹤0.01% 1989
2014
Q3 		$9K Hold
1,500
– – ﹤0.01% 2041
2014
Q2 		$10K Buy
1,500
+1,000
+200% +$11.3K ﹤0.01% 2029
2014
Q1 		$12K Sell
500
-88
-15% -$1.28K ﹤0.01% 1952
2013
Q4 		$6K Sell
588
-1,912
-76% -$21.1K ﹤0.01% 1962
2013
Q3 		$33K Buy
2,500
+2,000
+400% +$31.6K ﹤0.01% 1495
2013
Q2 		$7K Buy
+500
New +$6.74K ﹤0.01% 1878

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fifth Third Bancorp's ECYT Position: Q3 2015 in Review

Fifth Third Bancorp sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2015, closing a stake of 1,500 shares — an estimated $8K sold.

Fifth Third Bancorp first reported a position in ECYT in Q2 2013 and held it in 9 quarters. The position peaked at $33K in Q3 2013. 104 funds tracked by Wall St. Rank hold ECYT as of Q3 2015.

  • Fifth Third Bancorp reported no remaining Endocyte, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,500 Endocyte, Inc. Common Stock shares in Q3 2015, an estimated $8K.
  • Fifth Third Bancorp first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 9 quarters.
  • Fifth Third Bancorp's Endocyte, Inc. Common Stock position peaked at $33K in Q3 2013.
  • 104 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2015.

Based on Fifth Third Bancorp's 13F filing for Q3 2015, filed 13 Nov 2015.